The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
As of Oct 22, 2026
Oak Ridge portfolios delivered mixed relative results during the third quarter of 2026 against a shifting equity tape. Large-Cap and All-Cap strategies performed essentially in line with their respective Russell 1000 and 3000 Growth benchmarks, while Mid-Cap and Small-Cap portfolios gave back a portion of their first-half outperformance. The manager avoided major drawdowns in cyclical consumer exposures but experienced performance friction from an underweight in rebounding software names and pullbacks in datacenter-related industrial power suppliers and leading healthcare holdings. The broader macroeconomic landscape was defined by renewed monetary tightening as the Federal Reserve raised interest rates in September for the first time since 2023, propelling 10-year Treasury yields above 5% amid stubborn inflation and weakening consumer sentiment. Despite these headwinds, the manager maintains a constructive outlook on domestic economic expansion, noting that corporate artificial intelligence capital expenditures represent one-third of total corporate capex. Unlike the debt-funded 2000 telecom buildout, current enterprise infrastructure investments are supported by organic corporate cash flows. From a portfolio allocation standpoint, Oak Ridge trimmed high-flying technology names ahead of the index rebalance while preserving meaningful exposure to enterprise AI beneficiaries. Key positive attribution was driven by an overweight in cloud infrastructure and online retail alongside financial services platforms, offset by a sharp pullback in a core weight-loss biopharma position. Healthcare remains an anchor focus, particularly within bio/pharma companies exhibiting clear clinical catalysts and low debt, reinforced by M&A activity such as Vertex acquiring a portfolio holding.
Oak Ridge focuses on identifying leading growth companies with sustainable competitive advantages, disciplined balance sheets, and structural exposure to secular growth drivers like artificial intelligence infrastructure and biopharma innovation while prudently managing valuation risks.
Management expects sustained economic growth above 2% through 2027 and believes AI infrastructure spending will continue expanding despite short-term market digestion.
Neutral / Balanced
Market Conviction
Growth Outlook
Risk Appetite
Capital Deployment
Forward Guidance
Language Signal
Perceived Risk
Opportunity Density
Time Horizon
Top Conviction Themes
Key Catalysts
Every insight in this database connects to the original source. Read the actual thesis, see the actual concerns, and make your own call.
Buyside Digest has no business relationship, partnership, agency, sponsorship, endorsement, or affiliation with Oak Ridge investment or any other manager whose content appears on the Service, except where expressly stated. We do not receive Manager Content directly from managers in most cases; content is collected from publicly available sources. Managers have not necessarily reviewed, approved, authorized, or endorsed our display of their content, our editorial commentary, our metadata extraction, or our classifications. Use of a manager’s name is for accurate attribution and identification purposes only, under principles of nominative fair use.
Buyside Digest does not independently verify the regulatory status, registrations, licensing, qualifications, credentials, or professional standing of managers whose content appears on the Service. We do not represent that managers are properly registered with applicable regulatory bodies, that their content complies with applicable securities laws, or that their performance representations are accurate. Inclusion of a manager in our database is based on the publicly available nature of their content, not on our verification of their regulatory status or content compliance. Users are responsible for conducting their own due diligence on any manager.
Performance data, returns, assets under management (“AUM”), and similar figures displayed on this page are sourced from publicly available manager communications (including investor letters), public filings, or other third-party sources. Buyside Digest does not independently verify performance figures, calculate returns, or audit manager-reported data. Such figures: May be selectively reported by the manager; May use non-standard calculation methodologies; May not reflect fees, expenses, taxes, or other costs; May be inconsistent across reporting periods; May be outdated. Past performance is not indicative of future results. Performance figures should not be relied upon for investment decisions without independent verification. Users should request audited performance data directly from the manager and conduct their own due diligence.